title: The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
authors.forename: C
authors.initials: C
authors.lastname: Thomopoulos
authors.forename: C
authors.initials: C
authors.lastname: Tsioufis
authors.forename: T
authors.initials: T
authors.lastname: Makris
authors.forename: C
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D017311:Amlodipine / Q000494:pharmacology / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D015992:Body Mass Index; D015897:Comorbidity; D004359:Drug Therapy, Combination; D023381:Endpoint Determination; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology* / Q000503:physiopathology; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D008019:Life Style; D024821:Metabolic Syndrome / Q000453:epidemiology* / Q000503:physiopathology; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D007093:Imidazoles; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D017311:Amlodipine; C437965:olmesartan